Corey Goodman introduces Tallac Therapeutics with a $62M Series A, hoping to fight solid tumors through innate and adaptive immunity

When West Coast entrepreneur Corey Goodman and his colleagues at ALX Oncology came up with a new idea to potentially fight cancer, they knew they …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Corey Good­man in­tro­duces Tal­lac Ther­a­peu­tics with a $62M Se­ries A, hop­ing to fight sol­id tu­mors through in­nate and adap­tive im­mu­ni­ty